A federal judge allowed some claims accusing Epic Pharma Inc. of inflating the price of a drug to treat gallstones to proceed, while dismissing others as vague and lacking detail.
Eight separate complaints brought against New York-based Epic “contain sufficient detail to allege that Epic, with others, conspired to raise the price of Ursodiol,” Judge Cynthia M. Rufe of the US District Court for the Eastern District of Pennsylvania said in a Monday ruling. Three were dismissed.
Epic is among dozens of drug manufacturers accused of inflating the price of various generic drugs in multidistrict litigation that began in ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.